49 results
8-K
EX-99.1
EVOK
Evoke Pharma Inc
10 Aug 23
Evoke Pharma Reports Second Quarter 2023 Financial Results
9:03am
2023
Presented industry-leading real-world healthcare utilization data supporting the benefits of GIMOTI compared to oral metoclopramide at DDW 2023 … with GIMOTI used significantly less healthcare resources such as office visits, inpatient hospitalizations and emergency room visits compared to patients
8-K
EX-99.1
EVOK
Evoke Pharma Inc
9 Nov 23
Evoke Pharma Reports Third Quarter 2023 Financial Results
9:00am
Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients” Presented at The American College … A. Gonyer, R.Ph., Chief Executive Officer of Evoke Pharma.
“Only since May of this year, we began sharing insights from our healthcare resource
8-K
EX-99.1
EVOK
Evoke Pharma Inc
15 May 23
Evoke Pharma Reports First Quarter 2023 Financial Results
4:23pm
,” said David A. Gonyer, R.Ph., Evoke Pharma’s CEO.
“Insights from a recent survey, market data analysis, and patient and healthcare provider … ) “Orange Book”
Presented healthcare resource utilization real-world data analyses at leading medical meetings
Data abstract suggesting that GIMOTI (nasal
8-K
EVOK
Evoke Pharma Inc
9 May 23
Other Events
10:00am
the details of the Company's presentation at Digestive Disease Week 2023 demonstrating that GIMOTI reduces healthcare resource utilization … would result in lower healthcare resource utilization ("HCRU") compared to patients on oral metoclopramide. HCRU is the description and quantification
8-K
EX-99.1
EVOK
Evoke Pharma Inc
14 Mar 24
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
4:00pm
, R.Ph., CEO of Evoke Pharma. “The new Healthcare Resource Utilization (HCRU) data has only been available to our commercial team since near the end … as the Standard of Care for Diabetic Gastroparesis Treatment
Healthcare resource utilization data presented at DDW 2023 revealed
8-K
9v1c5 w6ly4f7cevj
1 Nov 23
Other Events
8:30am
8-K
sc7ki5ol
2 Dec 13
Departure of Directors or Certain Officers
12:00am
424B3
umkgnd 9xxah
14 Mar 24
Prospectus supplement
6:44pm
8-K
EX-99.1
7esnvez8
10 May 22
Evoke Pharma Reports First Quarter 2022 Financial Results
4:16pm
10-K
mrzi7
25 Mar 14
Annual report
12:00am
8-K
EX-99.1
dci ekxgklloih
10 Nov 21
Evoke Pharma Reports Third Quarter 2021 Financial Results
4:10pm